Lessons Learned from HSV/HIV Intervention Trials in South Africa
Author Information
Author(s): Delany-Moretlwe Sinead, Stadler Jonathan, Mayaud Philippe, Rees Helen
Primary Institution: University of the Witwatersrand, South Africa
Hypothesis
Can treatment for herpes simplex virus type 2 (HSV-2) serve as an effective strategy for HIV prevention?
Conclusion
Despite disappointing trial results showing no benefit of HSV-2 treatment for HIV prevention, important lessons were learned about the value of the communication process in building trust between researchers, community members, and policy-makers.
Supporting Evidence
- Researchers engaged with communities to build trust and understanding about the trials.
- Multiple communication methods were used to reach a broad audience.
- Despite the trials' disappointing results, they highlighted the importance of effective communication in research.
Takeaway
The study looked at how researchers communicated the results of trials testing herpes treatment for HIV prevention, and even though the results were not what they hoped, they learned how to better talk to communities about research.
Methodology
This case study reflects the experiences and discussions of researchers involved in communicating the results of four trials evaluating HSV-2 treatment for HIV prevention.
Potential Biases
Historical mistrust of research in South Africa may have influenced community perceptions and responses.
Limitations
The trials did not show a significant effect on HIV prevention, and the communication strategies may not have reached all participants effectively.
Participant Demographics
Participants included men, women, and couples, both HIV uninfected and HIV infected.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website